Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MamaceraM is a medical device consisting of ecological beeswax breast pads (mammary areolae) developed by the University of Alicante. These thin, rigid discs are handcrafted from approximately 9 grams of pure organic operculum beeswax and are designed to be placed directly on the nipple and areola of breastfeeding mothers. The device aims to prevent nipple lesions and improve breastfeeding adherence, particularly in primiparous women, by leveraging the natural moisturizing, antibacterial, antifungal, and anti-inflammatory properties of beeswax. Research conducted between 2017 and 2022 (NCT03676608) demonstrated that using these pads in combination with WHO health education significantly increased breastfeeding rates at 3 and 6 months postpartum compared to standard care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MamaceraM.